Critical micelle concentration and particle size determine adjuvanticity of cyclic lipopeptides-Reference-Cited by-同舟云学术

Critical micelle concentration and particle size determine adjuvanticity of cyclic lipopeptides

Published:2018-07-20 Issue:2 Volume:88 Page:e12698
ISSN:0300-9475
Container-title:Scandinavian Journal of Immunology
language:en
Short-container-title:Scand J Immunol

Author:

Yoshino Naoto¹^ORCID,Takeshita Ryosuke²,Kawamura Hanae²,Murakami Kazuyuki²,Sasaki Yutaka¹,Sugiyama Ikumi³,Sadzuka Yasuyuki³,Kagabu Masahiro²,Sugiyama Toru²,Muraki Yasushi¹,Sato Shigehiro¹

Affiliation:

1. Division of Infectious Diseases and Immunology; Department of Microbiology; School of Medicine; Iwate Medical University; Yahaba-cho Japan

2. Department of Obstetrics and Gynecology; School of Medicine; Iwate Medical University; Morioka Japan

3. Department of Advanced Pharmaceutics; School of Pharmacy; Iwate Medical University; Yahaba-cho Japan

Funder

Japan Society for the Promotion of Science

Keiryokai Research Foundation

Publisher

Wiley

Subject

Immunology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/sji.12698/fullpdf

Reference59 articles.

1. Prevention of bacterial infections of mucosal surfaces by immune secretory IgA;Cantey;Adv Exp Med Biol,1978

2. Mucosal immunity;Hanson;Ann N Y Acad Sci,1983

3. Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sites;Nizard;Hum Vaccin Immunother,2014

4. Surfactin, a crystalline peptidelipid surfactant produced by Bacillus subtilis: isolation, characterization and its inhibition of fibrin clot formation;Arima;Biochem Biophys Res Commun,1968

5. Polymyxin: a new chemotherapeutic agent;Stansly;Bull Johns Hopkins Hosp,1947

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Suitability of Polymyxin B as a Mucosal Adjuvant for Intranasal Influenza and COVID-19 Vaccines;Vaccines;2023-11-18

2. The relationship between the chemical structure, physicochemical properties, and mucosal adjuvanticity of sugar-based surfactants;European Journal of Pharmaceutics and Biopharmaceutics;2023-01

3. End-to-End Approach to Surfactant Selection, Risk Mitigation, and Control Strategies for Protein-Based Therapeutics;The AAPS Journal;2022-12-05

4. Study of the aggregation, interaction, and thermodynamic properties of the dodecyltrimethylammonium bromide & cefixime trihydrate mixture in sodium salts solution at numerous temperatures;Molecular Physics;2022-06-18

5. A systematic assessment of the relationship between synthetic surfactants and mucosal adjuvanticity;European Journal of Pharmaceutics and Biopharmaceutics;2021-08